Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FYQ22
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,112
Award facts
- Contract value 100% obligated
- $44,112.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order for Keytruda 100 mg/4 ml vials valued at $44,112.01. This firm fixed-price delivery order, issued on September 22, 2025, with an ultimate completion date of October 14, 2025, represents a single-item procurement without set-aside designation. The award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA's SPE2DB program, a $499.9 billion vehicle through November 2026 that enables the agency to issue delivery orders for a comprehensive pharmaceutical supply portfolio supporting military health facilities worldwide.
As an oncology immunotherapy medication, Keytruda is procured to support Department of Defense healthcare operations and the broader federal pharmaceutical supply chain managed through the Defense Logistics Agency. DMS Pharmaceutical Group's consistent positioning as a primary pharmaceutical distributor to DLA reflects its established capability to deliver both branded specialty drugs and routine pharmaceutical products directly to military medical facilities. The company's robust federal contract portfolio and long-term supplier status with the agency underscore its critical role in maintaining pharmaceutical inventory for military health systems.
Quick answers
Who was awarded contract SPE2DB25FYQ22?
SPE2DB25FYQ22 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FYQ22 worth?
The government has obligated $44,112 on SPE2DB25FYQ22.
Is contract SPE2DB25FYQ22 an order under another contract?
Yes. SPE2DB25FYQ22 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB25FYQ22 competed?
The extent of competition for SPE2DB25FYQ22 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award